Stock CUE CUE BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cue Biopharma, Inc.

Equities

CUE

US22978P1066

Market Closed - Nasdaq
Other stock markets
 01:30:00 13/06/2024 am IST 		5-day change 1st Jan Change
1.5 USD +2.04% Intraday chart for Cue Biopharma, Inc. -9.09% -43.18%
07/06 Cue Biopharma, Inc. Appoints Michael J. Fox to the Board of Directors and the Compensation Committee CI
09/05 Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CUE BIOPHARMA, INC. Stock Cue Biopharma, Inc.
 72.96M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 123B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 111B
BIONTECH SE Stock BioNTech SE
 23.63B -
ARGENX SE Stock argenx SE
 22.58B -
GENMAB A/S Stock Genmab A/S
 17.26B
  1. Stock Market
  2. Equities
  3. CUE Stock
  4. Charts Cue Biopharma, Inc.
  5. Sector Chart